As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.
The Senior Associate Director, Medical Affairs Strategy Team Member serves as the subject matter expert to create the indication-specific or product-specific Medical strategic framework and prioritized Medical tactics to ensure the success of the respective BI product(s) from a Medical Affairs perspective, both prior to and leading up to launch as well as throughout the product lifecycle. This individual will bring together strong technical knowledge of the therapeutic area, strong command of the relevant clinical practice guidelines and related scientific data as well as the understanding of the overall TA priorities and value drivers into an integrated strategic medical plan and tactics that enable the successful medical affairs contribution to BI’s portfolio and informs clinical development efforts where applicable. The incumbent will work with relevant stakeholders to drive integrated medical plans and executable tactics customized for organized customer channels including Health Systems and Payers.
The Senior Associate Director, Medical Affairs Strategy Team Member collaborates cross functionally within the larger Clinical Development & Medical Affairs (CDMA) department (e.g., Medicine Excellence, Field Medical Affairs, RWE, etc.) and across the organization (e.g., Marketing, Market Access, Analytics & Insights (A&I), HEOR, Clinical Operations, Patient Services, Legal, Compliance, etc.) and with global counterparts to create, execute, measure and adapt the Medical Affairs strategy to best fit the needs of the US clinical landscape and market dynamics of relevance to the respective TA.
